With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

The hospital failed to identify the patient as at-risk for a serious blot clot condition before discharging her, state ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

Boston Scientific Corp (NYSE:BSX) announced on Thursday that it has agreed to acquire medical technology company Penumbra ...

Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a ...

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...

Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190), a leading innovator in neurovascular and peripheral vascular interventional solutions, hosted its Investor Open Day at its Zhuhai Innovation ...

The experts we spoke with agreed on one thing: tight clothing has no place on a flight. "For long-haul flights, avoid ...

In a bold move to expand its cardiovascular portfolio, Boston Scientific Corporation has announced its acquisition of Penumbra, Inc. This strategic partnership, valued at approximately $14.5 billion, ...

Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.

Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence of vascular diseases Provides scaled entry into mechanical ...

Boston Scientific Corp (NYSE:BSX) said on Thursday it has reached a deal to acquire medical technology firm Penumbra ...